Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Feb. 02, 2019	Feb. 03, 2018	Jan. 28, 2017
OPERATING ACTIVITIES
Net income	$ 30,461,000	$ 8,540,000	$ 47,212,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	16,463,000	19,643,000	22,716,000
Provision For Doubtful Accounts	470,000	690,000	832,000
Purchase premium and premium amortization	576,000	3,834,000	783,000
Share Based Compensation	4,939,000	4,196,000	4,199,000
Excess tax benefits from share-based compensation	0	0	40,000
Deferred income taxes	1,285,000	1,176,000	(2,884,000)
Loss on disposal of property and equipment	1,089,000	2,127,000	2,060,000
Impairment	1,548,000	7,698,000	13,561,000
Changes in operating assets and liabilities which provided (used) cash:
Accounts receivable	(579,000)	1,780,000	5,442,000
Merchandise inventories	1,950,000	24,147,000	(4,581,000)
Prepaid and other assets	10,384,000	(7,459,000)	(9,877,000)
Accrued income taxes	(680,000)	(1,602,000)	879,000
Accounts payable, accrued expenses and other liabilities	(7,662,000)	(28,780,000)	(8,254,000)
Net cash provided by operating activities	60,244,000	35,990,000	72,128,000
INVESTING ACTIVITIES
Capital expenditures	(4,354,000)	(11,096,000)	(27,297,000)
Purchase of short-term investments	(157,515,000)	(15,770,000)	(113,031,000)
Sales of short-term investments	91,023,000	95,203,000	125,186,000
Purchase of Other Assets	(298,000)	(657,000)	(290,000)
Sales Of Other Assets	(7,000)	(6,000)	0
Change in restricted cash and investments	0	0	0
Net cash used in investing activities	(71,137,000)	67,686,000	(15,432,000)
FINANCING ACTIVITIES
Dividends paid	(32,577,000)	(33,731,000)	(35,432,000)
Repurchase of common stock	(13,344,000)	(38,878,000)	(42,564,000)
Proceeds from lines of credit	0	21,000,000	29,500,000
Payments to lines of credit	0	(21,000,000)	(29,500,000)
Proceeds from employee stock purchase plan	570,000	484,000	501,000
Excess tax benefits from share-based compensation financing activities	0	0	(40,000)
Proceeds From Stock Options Exercised	189,000	95,000	230,000
Net cash provided used in financing activities	(45,162,000)	(72,030,000)	(77,305,000)
Net increase in cash and cash equivalents	(56,055,000)	31,646,000	(20,609,000)
Cash and cash equivalents at beginning of period	78,047,000	49,618,000
Effect of Exchange Rate On Cash	0	0	0
Cash and cash equivalents at end of period	24,603,000	78,047,000	49,618,000
Change in Accrued PPE	326,000	634,000	1,099,000
Change in Accrued Treasury Stock	$ 0	$ 0	$ 1,853,000